Robbins Farley’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.3K | Hold |
460
| – | – | 0.01% | 102 |
|
|
2025
Q1 | $28.1K | Sell |
460
-100
| -18% | -$6.1K | 0.01% | 88 |
|
|
2024
Q4 | $31.7K | Hold |
560
| – | – | 0.02% | 89 |
|
|
2024
Q3 | $29K | Sell |
560
-330
| -37% | -$17.1K | 0.01% | 89 |
|
|
2024
Q2 | $37K | Sell |
890
-142
| -14% | -$5.9K | 0.02% | 82 |
|
|
2024
Q1 | $56K | Buy |
1,032
+191
| +23% | +$10.4K | 0.03% | 75 |
|
|
2023
Q4 | $43.2K | Sell |
841
-19
| -2% | -$975 | 0.03% | 78 |
|
|
2023
Q3 | $49.9K | Sell |
860
-31,721
| -97% | -$1.84M | 0.03% | 77 |
|
|
2023
Q2 | $2.08M | Sell |
32,581
-1,102
| -3% | -$70.5K | 1.44% | 31 |
|
|
2023
Q1 | $2.33M | Buy |
33,683
+1,449
| +4% | +$100K | 1.56% | 28 |
|
|
2022
Q4 | $2.32M | Sell |
32,234
-11,208
| -26% | -$806K | 1.79% | 25 |
|
|
2022
Q3 | $3.09M | Sell |
43,442
-1,094
| -2% | -$77.8K | 2.54% | 11 |
|
|
2022
Q2 | $3.43M | Sell |
44,536
-6,348
| -12% | -$489K | 3.57% | 7 |
|
|
2022
Q1 | $3.72M | Sell |
50,884
-3,705
| -7% | -$271K | 2.8% | 11 |
|
|
2021
Q4 | $3.4M | Buy |
54,589
+5,083
| +10% | +$317K | 2.52% | 16 |
|
|
2021
Q3 | $2.93M | Sell |
49,506
-5,352
| -10% | -$317K | 2.16% | 15 |
|
|
2021
Q2 | $3.67M | Buy |
54,858
+6,465
| +13% | +$432K | 4.14% | 8 |
|
|
2021
Q1 | $3.13M | Buy |
48,393
+1,682
| +4% | +$109K | 2.76% | 10 |
|
|
2020
Q4 | $2.9M | Buy |
+46,711
| New | +$2.9M | 2.85% | 10 |
|